carmustine has been researched along with rmp 7 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartus, RT; Blunt, DG; Dean, RL; Elliott, PJ; Hayward, NJ; Huff, MR; Nagle, TL; Snodgrass, PA | 1 |
| Bartus, RT; Dean, RL; Emerich, DF; Lafreniere, D; Marsh, J; Pink, M; Snodgrass, P | 1 |
2 other study(ies) available for carmustine and rmp 7
| Article | Year |
|---|---|
Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.
Topics: Animals; Autoradiography; Biomarkers; Blood-Brain Barrier; Bradykinin; Brain Neoplasms; Capillaries; Carbon Radioisotopes; Carboplatin; Carcinogens; Carmustine; Dextrans; Endothelium, Vascular; Female; Male; Neoplasm Transplantation; Plasma Substitutes; Rats; Rats, Inbred F344; Rats, Wistar; Tumor Cells, Cultured | 1996 |
Intravenous cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain.
Topics: Animals; Antineoplastic Agents; Autoradiography; Blood-Brain Barrier; Bradykinin; Brain; Brain Neoplasms; Carboplatin; Carmustine; Deoxycytidine; Gemcitabine; Male; Rats; Rats, Inbred F344; Vinblastine; Vinorelbine | 2000 |